Search results for "Relative risk"

showing 10 items of 303 documents

The occupational role of dental conditions among a consecutive sample of Spanish workers

2010

Objectives: To assess the occupational impact of the mouth in terms of days of work loss in the last year and the perception of the working performance disturbance because of the oral conditions. Study design: A consecutive sample (n=269) of the Regional Government staff of the province of Granada (Spain) was recruited. Participants were asked about work loss related to health problems in the past 12 months, capturing the aetiological entities, the frequency of the work absent and the total days loss. Also subjects reported if they believed that mouth affects their occupational performance, and if they have perceived difficulties for carrying out work because of the mouth. Data on sociodemo…

AdultMalePediatricsmedicine.medical_specialtyOral HealthOral healthCONSECUTIVE SAMPLEOral and maxillofacial pathologymedicineHumansGeneral DentistryOccupational HealthAgedDenture wearersbusiness.industryOdds ratioMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseOtorhinolaryngologySpainRelative riskUNESCO::CIENCIAS MÉDICASSick leaveEtiologyFemaleSurgerySick LeavebusinessDemographyMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Diesel motor emissions and lung cancer mortality--results of the second follow-up of a cohort study in potash miners.

2009

International health authorities have graded diesel motor emissions (DME) as probably cancerogenic in human beings. There are gaps in epidemiological evidence regarding exact exposure quantification, confounder control and the investigation of highly exposed populations. We investigated the association of DME ana lung cancer mortality in a historical cohort study of 5,862 German potash miners who were followed from 1970 to 2001. Cumulative exposure (CE) was measured by representative concentrations of total carbon multiplied with exposure years from the mines' medical records. Exposure and smoking behavior were validated by interviews of 3,087 participants. We computed standardized mortalit…

AdultMaleRiskCancer Researchmedicine.medical_specialtyLung NeoplasmsAdolescentCumulative ExposureComplex MixturesCohort StudiesOccupational ExposureEpidemiologyMedicineHumansstudyLung cancerChilddiesel motor emissionsAgedVehicle EmissionsAged 80 and overpotash miningbusiness.industryProportional hazards modellung cancer mortalityConfoundingCancercohortMiddle Agedmedicine.diseaseSurgeryOccupational DiseasesTreatment OutcomeOncologyRelative riskbusinessDemographyCohort studyInternational journal of cancer
researchProduct

Thirty-one novel biomarkers as predictors for clinically incident diabetes.

2010

Background The prevalence of diabetes is increasing in all industrialized countries and its prevention has become a public health priority. However, the predictors of diabetes risk are insufficiently understood. We evaluated, whether 31 novel biomarkers could help to predict the risk of incident diabetes. Methods and Findings The biomarkers were evaluated primarily in the FINRISK97 cohort (n = 7,827; 417 cases of clinically incident diabetes during the follow-up). The findings were replicated in the Health 2000 cohort (n = 4,977; 179 cases of clinically incident diabetes during the follow-up). We used Cox proportional hazards models to calculate the relative risk of diabetes, after adjustin…

AdultMaleRiskmedicine.medical_specialtyDiabetes riskPublic Health and Epidemiologylcsh:Medicine030209 endocrinology & metabolism030204 cardiovascular system & hematologyCohort Studies03 medical and health sciences0302 clinical medicineSex FactorsPredictive Value of TestsDiabetes mellitusInternal medicinemedicineDiabetes MellitusHumansCardiovascular Disorders/Vascular Biologylcsh:ScienceAgedApolipoproteins BProportional Hazards ModelsMultidisciplinaryAdiponectinbiologyProportional hazards modelbusiness.industrylcsh:RC-reactive proteinMiddle Agedmedicine.disease3. Good healthDiabetes and EndocrinologyC-Reactive ProteinROC CurveRelative riskImmunologyCohortFerritinsbiology.proteinlcsh:QFemaleAdiponectinbusinessBiomarkersCohort studyResearch ArticlePloS one
researchProduct

Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies.

2005

Abstract Background and aim The need to update tools for the estimate of cardiovascular risk prompted the “Gruppo di Ricerca per la Stima del Rischio Cardiovascolare in Italia” to produce a new chart and new software called Riskard 2005. Methods and results Data from 9 population studies in 8 Italian regions, for a grand total of 17,153 subjects (12,045 men and 5,108 women) aged 35–74 and for a total exposure of about 194,000 person/years were available. A chart for the estimate of cardiovascular risk (major coronary, cerebrovascular and peripheral artery disease events) in 10 years was produced for men and women aged 45–74 free from cardiovascular diseases. Risk factors employed in the est…

AdultMaleRiskmedicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulationMedicine (miscellaneous)Risk AssessmentDiabetes ComplicationsSex FactorsPredictive Value of TestsRisk FactorsSoftware DesignPrevalenceMedicineHumansRisk factoreducationAgededucation.field_of_studyNutrition and DieteticsFramingham Risk Scorebusiness.industrySmokingAbsolute risk reductionAge FactorsMiddle AgedSurgeryRisk EstimateCholesterolItalyCardiovascular DiseasesRelative riskHypertensionFemaleCardiology and Cardiovascular MedicinebusinessRisk assessmentBody mass indexAlgorithmsDemographyFollow-Up StudiesNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: a cohort study

2017

Abstract Background The association between multiple sclerosis (MS) and cancer has long been investigated with conflicting results. Several reports suggest an increased cancer risk among MS patients treated with immunosuppressant (IS) drugs. Methods We performed a cohort study including MS patients recruited at the Neurological Department of the University of Palermo. Mean follow-up period was ten years for the whole cohort. We calculated cancer incidence among patients treated with IS. Incidence rates were compared in the cohort by calculating the relative risk according to length and dose of exposure to IS. Cancer incidence among MS patients was compared to cancer incidence in the general…

AdultMaleRiskmedicine.medical_specialtyMultiple SclerosisPopulationlcsh:RC346-429Cohort StudiesYoung Adult03 medical and health sciences0302 clinical medicineNeoplasmsInternal medicinemedicineHumansMultiple sclerosiCancer; Cohort study; Immunosuppressant; Multiple sclerosis; Treatment; Neurology (clinical)Prospective cohort studyeducationlcsh:Neurology. Diseases of the nervous systemCancerImmunosuppressanteducation.field_of_studybusiness.industryIncidenceMultiple sclerosisCancerRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseSurgeryTreatment030220 oncology & carcinogenesisRelative riskCohortFemaleNeurology (clinical)Cohort studybusinessImmunosuppressive Agents030217 neurology & neurosurgeryResearch ArticleCohort studyBMC Neurology
researchProduct

Vitamin K antagonists' use and fracture risk: results from a systematic review and meta‐analysis

2015

Background: Although vitamin K antagonists (VKAs) lower serum values of bone deposition markers, the link with osteoporosis and fractures remains controversial. Objectives: To assess whether the use of VKAs is associated with an increased prevalence and/or incidence of osteoporosis, fractures, or lower bone mineral density (BMD) values. Methods: We conducted a systematic PubMed and EMBASE literature search until August 31, 2014, and a meta-analysis of cross-sectional and longitudinal studies investigating fractures and BMD, comparing patients treated with VKAs and healthy controls (HCs) or with patients with medical illness (medical controls, MCs). Standardized mean differences ± 95% and co…

AdultMaleRiskmedicine.medical_specialtyVitamin KBone mineral density; Coumadin; Fractures bone; Hip fractures; Osteoporosis; HematologyOsteoporosisbonefractures boneSex FactorsBone DensityInternal medicinemedicineHumansLongitudinal StudiesAgedBone mineralHip fracturebusiness.industryIncidenceIncidence (epidemiology)ConfoundingAge FactorsAnticoagulantsConfounding Factors EpidemiologicHematologyMiddle Agedmedicine.diseaseosteoporosisConfidence intervalSurgeryObservational Studies as TopicCross-Sectional StudiesFractures Spontaneouship fractureMeta-analysisRelative riskHip fracturescoumadinFemalebone mineral densitybusinessFracturesJournal of Thrombosis and Haemostasis
researchProduct

Diabetes and coronary risk factors. Relative risk for single factors and aggregation of more factors in a general population sample from northern Ita…

1990

In the course of a general population survey in Mirano (Venice), Northern Italy, a random sample of 1,903 subjects (50.1% men) aged 20-59 was examined. Fifty-five were diabetic (fasting plasma glucose greater than or equal to 140 mg/dl or diagnosed by a physician) and 1,670 non-diabetic subjects (fasting plasma glucose below 110 mg/dl). In this paper an assessment was made on the more frequent occurrence of coronary risk factors (serum cholesterol and triglycerides, body mass index (BMI), systolic blood pressure, cigarette smoking) and, in particular, of their aggregation in diabetic patients as compared to non-diabetic controls. The occurrence of any one of the coronary risk factors studie…

AdultMaleRural Populationmedicine.medical_specialtyEndocrinology Diabetes and MetabolismBlood PressureCoronary DiseaseBody Mass IndexDiabetes Complicationschemistry.chemical_compoundSex FactorsEndocrinologyRisk FactorsDiabetes mellitusInternal medicineEpidemiologyInternal MedicinemedicineHumansTriglyceridesCholesterolbusiness.industrySmokingAge FactorsCoronary risk factorsGeneral MedicineMiddle Agedmedicine.diseaseNorthern italyCholesterolBlood pressureEndocrinologyItalychemistryRelative riskFemalebusinessBody mass indexActa Diabetologica Latina
researchProduct

The 12-month prevalence of depression and health care utilization in the general population of Latvia.

2017

Abstract Background This cross-sectional study aims to assess the 12-month prevalence of major and minor depression in the Latvian population, and to evaluate associated health care utilization. Methods Trained interviewers conducted face-to-face interviews with a multistage stratified probability sample of the Latvian general population, ages 15–64 (n=3003). Participants were interviewed using the depression module of the Mini International Neuropsychiatric Interview. Self-reported health care utilization and somatic illness were also assessed. Multinomial logistic regressions were applied. Results The 12-month prevalence of major depression was 7.9% (95%CI 7.0–8.9), while for minor depres…

AdultMalemedicine.medical_specialtyAdolescentHealth StatusPopulationLogistic regressionSampling Studies03 medical and health sciencesYoung Adult0302 clinical medicineSex FactorsHealth careEpidemiologyOdds RatioPrevalenceMedicineHumansDisabled Persons030212 general & internal medicineeducationPsychiatryDepression (differential diagnoses)Mini-international neuropsychiatric intervieweducation.field_of_studyDepressive Disorderbusiness.industryDepressionAge FactorsHealth ServicesMiddle AgedPatient Acceptance of Health CareDisability pensionLatvia030227 psychiatryPsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesLogistic ModelsRelative riskFemaleSelf ReportbusinessDemographyJournal of affective disorders
researchProduct

Prediction Profiles for Nutritional Supplement Use Among Young German Elite Athletes

2014

Nutritional supplements (NS) are defined as concentrated sources of nutrients and other substances that have a nutritional or physiological effect and that are used in high frequency among athletes. The study aimed to create a prediction profile for young elite athletes to identify those athletes who have a higher relative risk for using NS. The second objective was to examine the hypothesis that the consumption of NS paves a gateway for the use of illicit drugs and doping substances. A self-designed anonymous paper-and-pencil questionnaire was used to examine the prevalence of NS consumption, doping, and illicit drug use in elite athletes with a mean age of 17 years (SD = 4 years). Logisti…

AdultMalemedicine.medical_specialtyAdolescentMedicine (miscellaneous)Performance-Enhancing SubstancesAthletic PerformanceLogistic regressionYoung AdultRisk-TakingGermanySurveys and QuestionnairesSupplement useEpidemiologyOdds RatiomedicineHumansOrthopedics and Sports MedicineElite athletesChildDoping in SportsConsumption (economics)Nutrition and DieteticsbiologyAthletesbusiness.industryAge FactorsGeneral Medicinemedicine.diseasebiology.organism_classificationSubstance abuseAthletesRelative riskDietary SupplementsRegression AnalysisFemalebusinessForecastingDemographyInternational Journal of Sport Nutrition and Exercise Metabolism
researchProduct

Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy

2014

Abstract Background Infliximab is effective as rescue therapy in severe corticosteroid-refractory ulcerative colitis. The optimal dose regimen and the long term benefits are not well defined. The aim of the present study was to evaluate short- and long-term colectomy rate in a cohort of patients with severe corticosteroid-refractory ulcerative colitis who received a three-dose infliximab induction regimen. Methods One hundred and thirteen patients admitted to 11 Italian IBD referral centres and treated with infliximab according to an intention to treat three-dose regimen were included. The co-primary endpoints were 3- and 12-month colectomy rate. The secondary end-points were the overall co…

AdultMalemedicine.medical_specialtyAdolescentSettore MED/12 - GASTROENTEROLOGIAmedicine.medical_treatmentUlcerative colitis;GastroenterologyDrug Administration ScheduleYoung AdultAdrenal Cortex HormonesInternal medicineHumansMedicineTreatment FailureAdverse effectColectomyInfliximab;AgedColectomyIntention-to-treat analysisbusiness.industryAnti-Inflammatory Agents Non-SteroidalGastroenterologyAntibodies MonoclonalGeneral MedicineMiddle Agedmedicine.diseaseUlcerative colitisInfliximabInfliximabRegimenTreatment OutcomeUlcerative colitisRelative riskCohortColitis UlcerativeFemalebusinessmedicine.drugJournal of Crohn's and Colitis
researchProduct